Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Through thick and thin: wasting, obesity, and TNF alpha.

Spiegelman BM, Hotamisligil GS.

Cell. 1993 May 21;73(4):625-7. Review. No abstract available.

PMID:
8500160
2.

Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice.

Heydrick SJ, Jullien D, Gautier N, Tanti JF, Giorgetti S, Van Obberghen E, Le Marchand-Brustel Y.

J Clin Invest. 1993 Apr;91(4):1358-66.

3.

IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells.

Wang LM, Myers MG Jr, Sun XJ, Aaronson SA, White M, Pierce JH.

Science. 1993 Sep 17;261(5128):1591-4.

PMID:
8372354
4.

The insulin signaling system.

White MF, Kahn CR.

J Biol Chem. 1994 Jan 7;269(1):1-4. Review. No abstract available.

5.

Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM.

Endocrinology. 1994 Jan;134(1):264-70.

PMID:
8275942
6.

Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A.

J Biol Chem. 1993 Dec 15;268(35):26055-8.

7.

Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8.

8.

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Hotamisligil GS, Shargill NS, Spiegelman BM.

Science. 1993 Jan 1;259(5091):87-91.

PMID:
7678183
9.

Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor.

Kasuga M, Karlsson FA, Kahn CR.

Science. 1982 Jan 8;215(4529):185-7.

PMID:
7031900
10.

Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Laemmli UK.

Nature. 1970 Aug 15;227(5259):680-5. No abstract available.

PMID:
5432063
11.

Insulin resistance in patients with colorectal cancer.

Copeland GP, Leinster SJ, Davis JC, Hipkin LJ.

Br J Surg. 1987 Nov;74(11):1031-5.

PMID:
3319027
12.

Monokine regulation of glucose transporter mRNA in L6 myotubes.

Cornelius P, Lee MD, Marlowe M, Pekala PH.

Biochem Biophys Res Commun. 1989 Nov 30;165(1):429-36.

PMID:
2556143
13.

Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.

Thies RS, Molina JM, Ciaraldi TP, Freidenberg GR, Olefsky JM.

Diabetes. 1990 Feb;39(2):250-9.

PMID:
2227134
14.
15.
16.

Insulin resistance--mechanisms, syndromes, and implications.

Moller DE, Flier JS.

N Engl J Med. 1991 Sep 26;325(13):938-48. Review. No abstract available.

PMID:
1881419
17.

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

Lang CH, Dobrescu C, Bagby GJ.

Endocrinology. 1992 Jan;130(1):43-52.

PMID:
1727716
18.

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.

Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF.

Nature. 1991 Jul 4;352(6330):73-7.

PMID:
1648180
19.

Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.

Grunfeld C, Feingold KR.

N Engl J Med. 1992 Jul 30;327(5):329-37. Review. No abstract available.

PMID:
1620172
20.

Supplemental Content

Support Center